AXS Investments LLC Sells 356 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

AXS Investments LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,526 shares of the healthcare conglomerate’s stock after selling 356 shares during the period. AXS Investments LLC’s holdings in UnitedHealth Group were worth $1,666,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Chelsea Counsel Co. bought a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $27,000. 25 LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $28,000. Freedom Wealth Alliance LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $31,000. Cascade Investment Advisors Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $28,000. Finally, Kalos Management Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $34,000. Institutional investors own 85.69% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 4,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the sale, the chief executive officer now directly owns 78,573 shares in the company, valued at $39,772,866.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Down 0.5 %

Shares of NYSE:UNH traded down $2.24 on Friday, hitting $474.34. 1,344,977 shares of the company’s stock were exchanged, compared to its average volume of 3,450,768. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $558.10. The stock has a market capitalization of $439.38 billion, a price-to-earnings ratio of 21.32, a price-to-earnings-growth ratio of 1.44 and a beta of 0.66. The business’s 50 day simple moving average is $490.92 and its two-hundred day simple moving average is $487.40. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, topping the consensus estimate of $5.92 by $0.22. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The business had revenue of $92.90 billion during the quarter, compared to the consensus estimate of $90.97 billion. During the same period last year, the company earned $5.57 earnings per share. The business’s revenue for the quarter was up 15.6% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be issued a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.59%. UnitedHealth Group’s payout ratio is currently 33.65%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on UNH shares. SVB Securities cut their price objective on shares of UnitedHealth Group from $625.00 to $560.00 in a report on Wednesday, June 14th. UBS Group increased their price objective on shares of UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a report on Wednesday, July 19th. Truist Financial cut their price objective on shares of UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday, June 14th. Piper Sandler initiated coverage on shares of UnitedHealth Group in a report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of UnitedHealth Group from $564.00 to $555.00 in a report on Monday, July 17th. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $577.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.